The FDA has rejected a nasal spray that would have been the first alternative to injections for treating severe allergic reactions. The agency is calling for more research on repeat doses of the drug epinephrine, which is used to halt anaphylaxis, a potentially life-threatening allergic reaction.
Researchers have used AI to develop a new drug that could potentially cure cancer.
DA says it needs more research before deciding to approve nasal spray to treat dangerous allergies
September 23, 2023.png)
.png)
.png)
